Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899244 | 0.98 | TSHR (0.30) | ALDH1A1 | |
| SCHEMBL28829489 | 0.98 | TSHR (0.30) | ALDH1A1 | |
| Methylamine SCHEMBL11565513 | 0.85 | ALDH1A1 (0.31) | ALDH1A1TDP1 | |
| SCHEMBL9416346 | 0.77 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9174583 | 0.76 | KCNA4 (0.32) | ALDH1A1TDP1 | |
| SCHEMBL13977379 | 0.75 | MME (0.31) | — | |
| SCHEMBL23833163 | 0.74 | L3MBTL1 (0.31) | — | |
| SCHEMBL29170291 | 0.73 | CYP2D6 (0.35) | — | |
| SCHEMBL13978035 | 0.73 | MME (0.31) | — | |
| SCHEMBL7164850 | 0.72 | LMNA (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3121162-B1 | PROCESS FOR PREPARING NITRATED HYDROCARBONS AND THEIR DERIVATIVES | ANGUS CHEMICAL (US) | 2021-05-26 | — | — | EP | disclosed |
| EP-3121162-A1 | NITRATED HYDROCARBONS AND DERIVATIVES | ANGUS CHEMICAL COMPANY (US) | 2017-01-25 | — | — | EP | disclosed |
| EP-2280927-B1 | PROCESSES FOR THE MANUFACTURE OF NITROBUTANE AND ITS DERIVATIVES | ANGUS CHEMICAL (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20140235548-A1 | COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION | CLEAVE BIOSCIENCES, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| US-20140235548-A1 | COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION | CLEAVE BIOSCIENCES, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| WO-2012158435-A1 | COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION | ZHOU HAN-JIE (US) | 2012-11-22 | — | — | WO | disclosed |
| US-20080160116-A1 | Compositions and Methods Comprising Zingiber Species | HERBALSCIENCE SINGAPORE PTE. LTD (SG) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080160116-A1 | Compositions and Methods Comprising Zingiber Species | AGL, SQLE, RBPJ | ALDH1A1 1755/4885TDP1 4873/4885 |
| US-20140235548-A1 | COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION | USP24, USP36, USP39 | ALDH1A1 4211/4885TDP1 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.